Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121). (Q45397323)
Jump to navigation
Jump to search
scientific article published on 7 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121). |
scientific article published on 7 February 2008 |
Statements
1 reference
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121). (English)
1 reference
Jean-François Bonfanti
1 reference
Christophe Meyer
1 reference
Frédéric Doublet
1 reference
Jérôme Fortin
1 reference
Philippe Muller
1 reference
Laurence Queguiner
1 reference
Tom Gevers
1 reference
Peggy Janssens
1 reference
Heidi Szel
1 reference
Rudy Willebrords
1 reference
Philip Timmerman
1 reference
Koen Wuyts
1 reference
Pieter van Remoortere
1 reference
Frans Janssens
1 reference
Piet Wigerinck
1 reference
Koen Andries
1 reference
7 February 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference